246 related articles for article (PubMed ID: 11182151)
1. Titin and ryanodine receptor autoantibodies in dogs with thymoma and late-onset myasthenia gravis.
Shelton GD; Skeie GO; Kass PH; Aarli JA
Vet Immunol Immunopathol; 2001 Jan; 78(1):97-105. PubMed ID: 11182151
[TBL] [Abstract][Full Text] [Related]
2. Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules.
Romi F; Bø L; Skeie GO; Myking A; Aarli JA; Gilhus NE
J Neuroimmunol; 2002 Jul; 128(1-2):82-9. PubMed ID: 12098514
[TBL] [Abstract][Full Text] [Related]
3. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies.
Romi F; Skeie GO; Aarli JA; Gilhus NE
Arch Neurol; 2000 Nov; 57(11):1596-600. PubMed ID: 11074791
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia.
Mygland A; Vincent A; Newsom-Davis J; Kaminski H; Zorzato F; Agius M; Gilhus NE; Aarli JA
Arch Neurol; 2000 Apr; 57(4):527-31. PubMed ID: 10768628
[TBL] [Abstract][Full Text] [Related]
5. Autoimmunity to ryanodine receptor and titin in myasthenia gravis is associated with GM allotypes.
Skeie GO; Pandey JP; Aarli JA; Gilhus NE
Autoimmunity; 1997; 26(2):111-6. PubMed ID: 9546812
[TBL] [Abstract][Full Text] [Related]
6. Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis. A study of IgG subclasses and clinical correlations.
Romi F; Skeie GO; Vedeler C; Aarli JA; Zorzato F; Gilhus NE
J Neuroimmunol; 2000 Nov; 111(1-2):169-76. PubMed ID: 11063835
[TBL] [Abstract][Full Text] [Related]
7. Muscle autoantibodies in subgroups of myasthenia gravis patients.
Romi F; Skeie GO; Aarli JA; Gilhus NE
J Neurol; 2000 May; 247(5):369-75. PubMed ID: 10896269
[TBL] [Abstract][Full Text] [Related]
8. Titin and ryanodine receptor antibodies in myasthenia gravis.
Skeie GO; Aarli JA; Gilhus NE
Acta Neurol Scand Suppl; 2006; 183():19-23. PubMed ID: 16637922
[TBL] [Abstract][Full Text] [Related]
9. Myasthenia gravis sera containing antiryanodine receptor antibodies inhibit binding of [3H]-ryanodine to sarcoplasmic reticulum.
Skeie GO; Lunde PK; Sejersted OM; Mygland A; Aarli JA; Gilhus NE
Muscle Nerve; 1998 Mar; 21(3):329-35. PubMed ID: 9486861
[TBL] [Abstract][Full Text] [Related]
10. IgG subclass distribution of ryanodine receptor autoantibodies in patients with myasthenia gravis and thymoma.
Mygland A; Tysnes OB; Aarli JA; Matre R; Gilhus NE
J Autoimmun; 1993 Aug; 6(4):507-15. PubMed ID: 8216692
[TBL] [Abstract][Full Text] [Related]
11. Anti-titin and antiryanodine receptor antibodies in myasthenia gravis patients with thymoma.
Baggi F; Andreetta F; Antozzi C; Simoncini O; Confalonieri P; Labeit S; Cornelio F; Mantegazza R
Ann N Y Acad Sci; 1998 May; 841():538-41. PubMed ID: 9668290
[No Abstract] [Full Text] [Related]
12. Pathogenesis of myositis and myasthenia associated with titin and ryanodine receptor antibodies.
Skeie GO; Romi F; Aarli JA; Bentsen PT; Gilhus NE
Ann N Y Acad Sci; 2003 Sep; 998():343-50. PubMed ID: 14592894
[TBL] [Abstract][Full Text] [Related]
13. Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin.
Gautel M; Lakey A; Barlow DP; Holmes Z; Scales S; Leonard K; Labeit S; Mygland A; Gilhus NE; Aarli JA
Neurology; 1993 Aug; 43(8):1581-5. PubMed ID: 8351016
[TBL] [Abstract][Full Text] [Related]
14. Anti-cardiac ryanodine receptor antibodies in thymoma-associated myasthenia gravis.
Mygland A; Tysnes OB; Matre R; Aarli JA; Gilhus NE
Autoimmunity; 1994; 17(4):327-31. PubMed ID: 7948615
[TBL] [Abstract][Full Text] [Related]
15. A case of late-onset, thymoma-associated myasthenia gravis with ryanodine receptor and titin antibodies and concomitant granulomatous myositis.
Stefanou MI; Komorowski L; Kade S; Bornemann A; Ziemann U; Synofzik M
BMC Neurol; 2016 Sep; 16(1):172. PubMed ID: 27623618
[TBL] [Abstract][Full Text] [Related]
16. Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis.
Mygland A; Aarli JA; Matre R; Gilhus NE
J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):843-6. PubMed ID: 8021674
[TBL] [Abstract][Full Text] [Related]
17. Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis.
Romi F; Gilhus NE; Varhaug JE; Myking A; Skeie GO; Aarli JA
Eur J Neurol; 2002 Jan; 9(1):55-61. PubMed ID: 11784377
[TBL] [Abstract][Full Text] [Related]
18. Paraneoplastic myasthenia gravis: immunological and clinical aspects.
Skeie GO; Romi F
Eur J Neurol; 2008 Oct; 15(10):1029-33. PubMed ID: 18717725
[TBL] [Abstract][Full Text] [Related]
19. Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence?
Buckley C; Newsom-Davis J; Willcox N; Vincent A
Neurology; 2001 Nov; 57(9):1579-82. PubMed ID: 11706095
[TBL] [Abstract][Full Text] [Related]
20. Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study.
Romi F; Gilhus NE; Varhaug JE; Myking A; Aarli JA
Eur J Neurol; 2003 Nov; 10(6):701-6. PubMed ID: 14641516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]